Provides that it is unlawful for any person to directly or indirectly own, operate, or control the whole or any part of a health insurance company and a health care provider; requires divestment within three years.
S09192 would add a new section to the General Obligations Law prohibiting overlapping ownership, operation, or control between health insurance companies and health care providers. The bill defines both categories broadly, covering insurers and HMOs on one side and a wide range of providers on the other, including licensed facilities, mental health facilities, fiscal intermediaries, health professionals, and suppliers of pharmaceutical products, services, or durable medical equipment. It also defines “indirect control” expansively to include arrangements or ownership interests that allow one side to influence the operations of the other.
Under the bill, it would be unlawful for any person to directly or indirectly own, operate, or control both a health insurance company and a health care provider, or any part of both. Any person found in violation would have up to three years after the effective date to divest from the conflicting ownership or control interests. The Attorney General would be authorized to enforce the law through a civil action and could seek a civil penalty of $10,000 per day, plus costs and reasonable attorneys’ fees. The bill would take effect immediately upon enactment.
The bill would create a new state-law restriction on vertical integration and cross-ownership in the health care and insurance markets, adding a divestment mandate to the General Obligations Law. It would affect insurers, HMOs, hospitals, clinics, mental health facilities, fiscal intermediaries, licensed health professionals, and medical suppliers that have ownership or control relationships across the payer-provider divide. The Attorney General would gain explicit enforcement authority and a significant civil penalty tool to compel compliance.
Based on the bill text and the absence of recorded committee debate or votes in the provided materials, the bill appears to be framed as a structural reform measure aimed at separating insurance and provider interests. The caption and drafting suggest a policy goal of reducing conflicts of interest and limiting market concentration. No contrary sentiment is documented in the supplied record, but the breadth of the prohibition indicates the measure could draw support from advocates of market separation and scrutiny from entities with integrated insurance-provider business models.
The main point of contention is likely the bill’s broad ban on any direct or indirect overlapping ownership or control, which could reach complex corporate affiliations, management agreements, and investment structures. Another likely issue is the three-year divestment requirement, which may be viewed as burdensome for integrated health systems, insurers, and investors that currently operate across both sectors. The expansive definition of “indirect control” and the Attorney General’s ability to impose daily penalties may also be contested by affected industry stakeholders as overly broad or punitive.